Fennec Pharmaceuticals Inc. (FRX.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 220.58M |
| Enterprise Value | 183.86M |
| P/E Ratio | -31.16 |
| PEG Ratio | -2.23 |
| Price/Sales Ratio | 6.52 |
| Price/Book Ratio | 8.72 |
| Enterprise/Revenue | 5.73 |
| Enterprise/EBITDA | -43.8 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.16 |
| Operating Margin | -0.11 |
AD
Management Effectiveness
| Return On Assets | -0.12 |
| Return On Equity | -0.55 |
Income Statement
| Revenue | 44.64M |
| Revenue/Share | 1.49 |
| Gross Profit | 40.88M |
| EBITDA | -7.45M |
| Net Income | -9.74M |
| Diluted EPS | -0.34 |
Balance Sheet
| Total Cash | 40.08M |
| Total Cash/Share | 1.17 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 6.98 |
| Book Value Per Share | 1.1 |
Price History
| 52-Week Change | 25.79 |
| 52-Week High | 15.48 |
| 52-Week Low | 7.59 |
| Moving Average 50 Days | 13.92 |
| Moving Average 200 Days | 11.4 |
Statistics
| Average Volume | 1,066 |
| Shares Outstanding | 34.74M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
| Last Split Date | September 05, 2014 |
AD
